ICOA
IBB icon

Investment Centers of America’s iShares Biotechnology ETF IBB Stock Holding History

Investment Centers of America’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,573
Closed -$731K – 204
2017
Q3 		$731K Sell
6,573
-84
-1% -$8.98K 0.05% 270
2017
Q2 		$688K Buy
6,657
+3,342
+101% +$329K 0.05% 291
2017
Q1 		$326K Sell
3,315
-267
-7% -$25.6K 0.03% 450
2016
Q4 		$317K Buy
3,582
+762
+27% +$69.4K 0.03% 422
2016
Q3 		$273K Sell
2,820
-504
-15% -$47.9K 0.03% 402
2016
Q2 		$286K Buy
3,324
+414
+14% +$37.1K 0.03% 364
2016
Q1 		$251K Sell
2,910
-8,490
-74% -$759K 0.03% 400
2015
Q4 		$1.28M Buy
11,400
+951
+9% +$103K 0.17% 141
2015
Q3 		$1.05M Buy
+10,449
New +$1.25M 0.16% 147

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Investment Centers of America's IBB Position: Q4 2017 in Review

Investment Centers of America sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 6,573 shares — an estimated $731K sold.

Investment Centers of America first reported a position in IBB in Q3 2015 and held it in 9 quarters. The position peaked at $1.28M in Q4 2015. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • Investment Centers of America reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 6,573 iShares Biotechnology ETF shares in Q4 2017, an estimated $731K.
  • Investment Centers of America first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 9 quarters.
  • Investment Centers of America's iShares Biotechnology ETF position peaked at $1.28M in Q4 2015.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.